IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.
About IPO Scanner
IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.
Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.
Details of client bank account
For any query / feedback / clarifications, email at
[email protected].
Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.
© 2026 IPO Scanner. All rights reserved.
Want to stay updated?Subscribe to our newsletter

Open Date
May 21, 2026
Close Date
May 25, 2026
Min Investment
₹2,78,000
Lot Size
1000 Shares
Issue Size
₹52.43 Cr
Price Range
₹132 - ₹132
Listing Date
The Bio Medica Laboratories deals in the manufacture of parenteral formulations that involve the development and supply of ethical drug products, generics, and over-the-counter drugs in liquid and dry powder forms for injection purposes. Product Portfolio: 58 products are present in liquid injectable forms Dry powder injectable form of products is also supplied with 15 such products It supplies various types of products like generic drugs, proprietary drugs, over the counter drugs, and others. Business Model: The Bio Medica Laboratories function as a business to business organization dealing only in contract manufacturing of its products. It develops formulations of different products as per the requirements of various organizations. It is licensed for good manufacturing practices (GMP) and good laboratory practices (GLP) as certified by the Food & Drugs Administration, Madhya Pradesh. Manufacturing plants: Two plants are located in Indore district of Madhya Pradesh.
Sotefin Bharat
| Companies Name | Open - Close | Issue Size | Min. Qty | Issue Price | Apply |
|---|---|---|---|---|---|
Sotefin Bharat SME | 16th Jul 2026 - 20th Jul 2026 | 89.76 Cr | 600 Shares | ₹ 178.00 | |
Caliber Mining & Logistics Mainboard | 17th Jul 2026 - 21st Jul 2026 | 450.00 Cr | 35 Shares | ₹ 402.00 |
May 29, 2026
IPO Doc
RHP PDFRevenue Growth
Company Valuation
Earning Expansion
The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily.
The company will utilise ₹6.50 crore for repayment of loan. The company will utilise ₹28.50 crore to setup new manufacturing facility at existing premises Part of the IPO proceeds will be used for general corporate purposes and issue expenses
Repayment of loan
13.7%
Set up of new facility
60.3%
General corporate purposes
25.8%
The company will utilise ₹6.50 crore for repayment of loan.
The company will utilise ₹28.50 crore to setup new manufacturing facility at existing premises
Part of the IPO proceeds will be used for general corporate purposes and issue expenses
Times subscribed by category (bars capped at 10x for readability). Dashed line marks 1.0x (fully subscribed).
In Cr.
Bio Medica Laboratories
Plot No. 11B-11C, Sector-E, Sanwer Road, Industrial Area, Industrial Estate (Indore), Indore, Madhya Pradesh - 452015.